EP4129336
ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCER
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
11.2.2019:
7.5.2025:
22183160.5
:
10.2.2039:
10.2.2026
:
ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCER
11.2.2019
7.5.2025
10.2.2026
:
Forty Seven, LLC:
333 Lakeside Drive, Foster City, CA 94404, US
:
CHAO, Mark Ping:
Foster City 94404, US
:
TAKIMOTO, Chris Hidemi Mizufune:
Foster City 94404, US
:
VOLKMER, Jens-Peter:
Foster City 94404, US
:
201862629340 P:
12.2.2018:
US
:
201862678468 P:
31.5.2018:
US
:
201862743060 P:
9.10.2018:
US
:
201862743875 P:
10.10.2018:
US
:
A61K 39/395, C07K 16/28, A61P 35/00